Literature DB >> 9616153

Rapid activation of protein C by factor Xa and thrombin in the presence of polyanionic compounds.

A R Rezaie1.   

Abstract

A recent study indicated that negatively charged substances such as heparin and dextran sulfate accelerate thrombin activation of coagulation factor XI by a template mechanism. Because the serine proteinase of the natural anticoagulant pathway, activated protein C, can bind heparin, it was reasonable to think that these compounds may also bind protein C (PC) and accelerate its activation by thrombin or other heparin binding plasma serine proteinases by a similar mechanism. To test this, PC activation by thrombin and factor Xa (fXa) was studied in the presence of these polysaccharides. With thrombin in the absence of thrombomodulin (TM), these polysaccharides markedly reduced the Km for PC and Gla-domainless PC (GDPC) activation in the presence of Ca2+. With TM containing chondroitin sulfate, heparin did not influence PC activation by thrombin, but with TM lacking chondroitin sulfate, the characteristic high-affinity PC interaction at low Ca2+ (approximately 50 to 100 micromol/L) was largely eliminated by heparin. In EDTA, heparin enhanced thrombin activation of GDPC by reducing the Km, but it inhibited PC activation by increasing the Km. PC activation in EDTA was insensitive to the presence of heparin if the exosite 2 mutant, R93,97,101A thrombin, was used for activation. These results suggest that, when the Gla-domain of PC is not fully stabilized by Ca2+, it interacts with the anion binding exosite 2 of thrombin and that heparin binding to this site prevents this interaction. Additional studies indicated that, in the presence of phospholipid vesicles, heparin and dextran sulfate dramatically accelerate PC activation by fXa by also reducing the Km. Interestingly, on phospholipids containing 40% phosphatidylethanolamine, the activation rate of near physiological PC concentrations ( approximately 80 nmol/L) by fXa in the presence of dextran sulfate was nearly comparable to that observed by the thrombin-TM complex. The biochemical and potential therapeutical ramifications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9616153

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Polyphosphate elicits pro-inflammatory responses that are counteracted by activated protein C in both cellular and animal models.

Authors:  J-S Bae; W Lee; A R Rezaie
Journal:  J Thromb Haemost       Date:  2012-06       Impact factor: 5.824

2.  Extraembryonic expression of EPCR is essential for embryonic viability.

Authors:  Weihong Li; Xunzhen Zheng; Jian-Ming Gu; Gary L Ferrell; Mingming Brady; Naomi L Esmon; Charles T Esmon
Journal:  Blood       Date:  2005-06-14       Impact factor: 22.113

3.  Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice.

Authors:  L R Jalbert; E D Rosen; L Moons; J C Chan; P Carmeliet; D Collen; F J Castellino
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

4.  Thrombomodulin allosterically modulates the activity of the anticoagulant thrombin.

Authors:  Alireza R Rezaie; Likui Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-01       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.